RESUMEN
OBJECTIVE: The aim of this study was to validate the classification of bisphosphonate-related osteonecrosis of the jaws (BRONJ) published in 2009(17) in a series of cases. MATERIAL AND METHODS: This retrospective clinical study included a series of 102 cases (81%) of intravenous BRONJ (iBRONJ, group 1) and 24 cases (19%) of oral BRONJ (oBRONJ, group 2). We recorded all patients' symptoms and clinical findings and classified each patient into a BRONJ stage (0-3; stage 0=non-exposed BRONJ). RESULTS: Most BRONJ cases (n=120, 95.2%) could be classified according to the proposed stages. Exposed necrotic areas of bone were more prevalent in group 1 than in group 2 (p<0.05). In contrast, we observed more BRONJ cases without areas of exposed bone in group 2 (n=12, 50%) than in group 1 (n=14, 13.7%; p<0.05). We could not assign six cases to any of the proposed stages. These cases had no areas of exposed necrotic bone, but had mandibular fractures, extra-oral fistula or affected maxillary sinuses. CONCLUSIONS: In our series, iBRONJ cases showed more advanced stages of BRONJ than did oBRONJ cases. We found few cases that could not be classified into any proposed stage because they had findings associated with stages 0 and 3 but lacked exposed necrotic bone.
Asunto(s)
Osteonecrosis de los Maxilares Asociada a Difosfonatos/clasificación , Conservadores de la Densidad Ósea/administración & dosificación , Difosfonatos/administración & dosificación , Administración Intravenosa , Administración Oral , Anciano , Anciano de 80 o más Años , Osteonecrosis de los Maxilares Asociada a Difosfonatos/diagnóstico , Conservadores de la Densidad Ósea/efectos adversos , Difosfonatos/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Estudios RetrospectivosRESUMEN
INTRODUCTION: This preliminary study compared the epidermal growth factor receptor (EGFR) copy number in patients with potentially malignant oral disorders (PMODs) and oral squamous cell carcinoma (OSCC). MATERIAL AND METHODS: Group 1 comprised 20 patients with oral leukoplakia and group 2 comprised 19 cases of OSCC. We estimated the EGFR copy number in both groups using real-time reverse-transcription polymerase chain reaction assays. We used laser microdissection (LMD) for EGFR amplification, and overexpression was performed. RESULTS: The EGFR copy number was higher in group 2 (9.1 ± 6.2) than in group 1 (3.8 ± 1.5). The greatest copy number was found in the non-homogeneous leukoplakias, but the difference in homogeneous cases was not significant (Mann-Whitney test, P>0.05). In group 2, the EGFR copy number was higher in advanced stages than in early stages, but again lacked statistical significance. CONCLUSIONS: The EGFR copy number may be a useful biomolecular marker to differentiate PMODs from OSCC. The EGFR was higher in non-homogeneous leukoplakias and in the advanced stages of OSCC.
Asunto(s)
Carcinoma de Células Escamosas/genética , Receptores ErbB/genética , Dosificación de Gen/genética , Leucoplasia Bucal/genética , Neoplasias de la Boca/genética , Biomarcadores de Tumor/análisis , Carcinoma de Células Escamosas/secundario , Receptores ErbB/análisis , Femenino , Amplificación de Genes/genética , Regulación Neoplásica de la Expresión Génica/genética , Humanos , Terapia por Láser , Metástasis Linfática/genética , Masculino , Microdisección , Persona de Mediana Edad , Estadificación de Neoplasias , Lesiones Precancerosas/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa InversaRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Adulto Joven , Sarcoma/cirugía , Sarcoma , Colgajos Quirúrgicos , Recurrencia Local de Neoplasia/complicaciones , Recurrencia Local de Neoplasia/diagnóstico , Fotomicrografía/métodos , Fotomicrografía , Vértebras Cervicales/patología , Vértebras Cervicales/cirugía , Vértebras Cervicales , Diagnóstico DiferencialRESUMEN
Quality of life (QL) in oral cancer patients has become one of the most important parameters to consider in the diagnosis and post-treatment follow-up. The purpose of this article has been to review the papers published that study the QL in oral cancer patients, the different QL questionnaires used, the clinical results obtained, and the systematic revisions available in the indexed literature for the last 10 years. The term QL appears as a keyword in an increasing number of articles throughout the past 10 years; however, few studies focus on oral cancer. Most of them assess all head and neck cancers, which conform to a heterogeneous group with several different features depending on location (oral cavity, oropharynx, larynx, hypopharynx, nasopharynx and salivary glands). Most studies evaluate QL in short periods of time, normally within the first year after the diagnosis. Series do not discern between different therapeutic options, and they generally center on Northern European or Northern American populations. There are few instruments translated and validated into Spanish that measure QL, a fundamental characteristic to link QL to own patients' socio-cultural parameters. Data related with QL are mostly related to patient (age, sex, co-morbidity), tumour (location, size), and treatment (surgical treatment, radiotherapy association, reconstruction, cervical dissection, and/or feeding tube). Nowadays QL's assessment is considered an essential component of an oral cancer patient as well as the survival, morbidity and years free of disease. Although many aspects related to QL in oral cancer patients have been published throughout the past 10 years, more systematic research is needed to be able to apply it on a daily basis.
Asunto(s)
Neoplasias de la Boca , Calidad de Vida , Humanos , Neoplasias de la Boca/terapia , Factores Socioeconómicos , Encuestas y CuestionariosRESUMEN
Quality of life (QL) in oral cancer patients has become one of the most important parameters to consider in thediagnosis and post-treatment follow-up. The purpose of this article has been to review the papers published that studythe QL in oral cancer patients, the different QL questionnaires used, the clinical results obtained, and the systematicrevisions available in the indexed literature for the last 10 years.The term QL appears as a keyword in an increasing number of articles throughout the past 10 years; however, fewstudies focus on oral cancer. Most of them assess all head and neck cancers, which conform to a heterogeneous groupwith several different features depending on location (oral cavity, oropharynx, larynx, hypopharynx, nasopharynx andsalivary glands). Most studies evaluate QL in short periods of time, normally within the first year after the diagnosis.Series do not discern between different therapeutic options, and they generally center on Northern European orNorthern American populations. There are few instruments translated and validated into Spanish that measure QL,a fundamental characteristic to link QL to own patients socio-cultural parameters. Data related with QL are mostlyrelated to patient (age, sex, co-morbidity), tumour (location, size), and treatment (surgical treatment, radiotherapyassociation, reconstruction, cervical dissection, and/or feeding tube). Nowadays QLs assessment is considered anessential component of an oral cancer patient as well as the survival, morbidity and years free of disease. Althoughmany aspects related to QL in oral cancer patients have been published throughout the past 10 years, more systematicresearch is needed to be able to apply it on a daily basis (AU)